SIFI SpA

Since 1935 committed to improving patients quality of vision. SIFI is expanding into international markets providing innovative solutions for ocular diseases.

[SIFI SpA @sifigroup]

We are delighted to share with you our important regulatory progress in EU and the US for the treatment of the acute and devastating disease of acanthamoeba keratitis.
Read the follow article for more details:
https://t.co/cdIMfV1OaW
#acanthamoebakeratitis #ophthalmology

[SIFI SpA @sifigroup]

Happy to announce Phase III study on polihexanide 0,08% monotherapy in adults and adolescents with Acanthamoeba keratitis (AK), met its primary endpoint of ‘clinical resolution rate over a 12-month timeframe’.

To read the full article:
https://t.co/8TSczaTlZO

[SIFI SpA @sifigroup]

Siamo lieti di comunicare che AIFA, ha autorizzato la modifica della posologia di NETILDEX® gel oftalmico con riduzione del numero di somministrazioni giornaliere da 4 a 2.

📌Per saperne di più:
https://t.co/wmRPUDDRfd

#innovation #ophthalmology #cataractsurgery

[SIFI SpA @sifigroup]

Thank you to @GBReports for the interview to our CEO @fabrichines

[Global Business Reports @GBReports]

Sicily-based ophthalmic product specialist SIFI Group has grown since its establishment in 1935.

Last year, they launched Well Fusion, a novel formulation of artificial tears.

To find out below about their innovations, read our itw with Fabrizio Chines.
https://t.co/gQ7SLwCyhX

[Global Business Reports @GBReports]

Sicily-based ophthalmic product specialist SIFI Group has grown since its establishment in 1935.

Last year, they launched Well Fusion, a novel formulation of artificial tears.

To find out below about their innovations, read our itw with Fabrizio Chines.
https://t.co/gQ7SLwCyhX

[SIFI SpA @sifigroup]

Lamik teaches his younger sister Grace how to wash her hands and face to protect herself from the risks of #trachoma, the world’s leading infectious cause of #blindness. SIFI is proud to support @Sightsavers & fight this terrible #disease. #eyes #ophthalmology #prevention #vision

[SIFI SpA @sifigroup]

Click to read the Executive Summary of the "TFOS European Ambassador meeting: Unmet needs and future scientific and clinical solutions for ocular surface diseases” report: https://t.co/7sIL9N98b6 #ophthalmology #vision #dryeye #science #health #eyehealth #lifesciences @Eyeppl

[SIFI SpA @sifigroup]

Evento SIFI in occasione della BIO Digital International Convention 2021 : https://t.co/aZqFZmkUNQ #innovazione #salute #ricerca #tecnologia #oftalmologia

[SIFI SpA @sifigroup]

BIO Digital 2021 @IAmBiotech will be an opportunity to present some of SIFI’s most significant #research projects with a view to identify strategic partners for some of its late-stage assets and patented drug-delivery platforms. https://t.co/HIcjtrpk6i #innovation #biotech

[SIFI SpA @sifigroup]

SIFI to Present at BIO Digital International Convention 2021. https://t.co/uckGiFtoWs #biotech #pharma #innovation #research #science #health #eyehealth #industry #technology

[SIFI SpA @sifigroup]

SIFI sbarca in Russia per offrire una miglior cura degli occhi: https://t.co/ljQECEapLD #salute #farmaceutica #innovazione #oftalmologia #italia #russia @MilanoFinanza

[AboutPharma @AboutPharmaHPS]

#Oftalmologia, accordo tra l’italiana Sifi e Bausch Health Russia https://t.co/J9NdFVD9wu

[SIFI SpA @sifigroup]

On @EyewireNews Gilberto Dalesio SIFI’s CCO "SIFI is committed to continuous development and expansion and is pleased to announce this strategic partnership with Bausch Health Russia." https://t.co/1vST7MV0kO #pharma #ophthalmology #health #industrynews #Pharmaceuticals #Russia

[SECOIR @SECOIR_oficial]

Hoy a las 18:00 h. en el 36 Congreso #SECOIR2021 el simposio de @sifigroup con los expertos Dr. Güell, Prof. Auffarth y Dr. Ruiz Mesa que nos presentarán un innovador sistema de lentes de visión ininterrumpida. Más información e inscripciones en 👁️‍🗨️ https://t.co/bxwQTDEcim

[SIFI SpA @sifigroup]

SIFI e Bausch Health Russia annunciano una partnership commerciale strategica in Russia che garantirà un maggiore accesso a importanti farmaci per la cura degli occhi: https://t.co/y9hI99fcLK #occhi #salute #oftalmologia #farmaceutica

[SIFI SpA @sifigroup]

SIFI and Bausch Health Russia Announce Strategic Commercial Partnership that Will Ensure Greater Access to Important Eye Care Medicines in Russia: https://t.co/Jpg2zxQFff #pharma #pharmanews #eyecare #health #biotech #ophthalmology #industrynews

[SIFI SpA @sifigroup]

When we work on a screen, our blink rate is significantly reduced (three times less). The tear film does not renew itself regularly, but evaporates and the eye dries: https://t.co/c6h7FPfQlu #eyes #vision #prevention #dryeye #health #eyehealth #healthylifestyle

[SIFI SpA @sifigroup]

Oggi su @Adnkronos +++ SIFI annuncia avvio l'arruolamento dei pazienti nella sperimentazione clinica di Fase II volta a valutare Pro-ocular nella malattia dell'occhio secco - https://t.co/dwaY9X8BTB #dryeye #occhiosecco #oftalmologia #innovazione #ricerca #clinicaltrial #pharma

[SIFI SpA @sifigroup]

On @EyewireNews +++ SIFI Initiates Patient Enrollment in Phase 2 Trial Evaluating Pro-Ocular in Dry Eye Disease https://t.co/gqG0LmvJ9W #dryeye #Ophthalmology #Clinicaltrial #research #science #innovation #eyehealth #pharma

[SIFI SpA @sifigroup]

SIFI Initiates Patient Enrollment in Phase II Trial evaluating Pro-ocular in Dry Eye Disease. Trial involves 4 leading ophthalmic centers in Italy & is expected to recruit 105 participants: https://t.co/0jmTmOcGg1 #dryeye #innovation #research #biotech #pharma #Ophthalmology